drugset / Trial / NCT00002228

A Study of T-20 in HIV-Positive Adults

NCT00002228

Phase 2 Completed 78 enrolled Trimeris
Treatment

Summary

The purpose of this study is to see if it is safe and effective to give T-20 to HIV-positive adults. T-20 is an anti-HIV drug.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Enfuvirtide Peptide Subcutaneous